140 related articles for article (PubMed ID: 31697433)
1. Evaluation of Sacral Nerve Stimulation Device Revision and Explantation in a Single Center, Multidisciplinary Study.
Gevelinger MM; Sanderson DJ; Jaworski E; Doyle PJ
Neuromodulation; 2020 Dec; 23(8):1201-1206. PubMed ID: 31697433
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for explantation due to infection after sacral neuromodulation: a multicenter retrospective case-control study.
Myer ENB; Petrikovets A; Slocum PD; Lee TG; Carter-Brooks CM; Noor N; Carlos DM; Wu E; Van Eck K; Fashokun TB; Yurteri-Kaplan L; Chen CCG
Am J Obstet Gynecol; 2018 Jul; 219(1):78.e1-78.e9. PubMed ID: 29630890
[TBL] [Abstract][Full Text] [Related]
3. Impact of Age and Comorbidities on Use of Sacral Neuromodulation.
Faris AER; Gill BC; Pizarro-Berdichevsky J; Dielubanza E; Clifton MM; Okafor H; Goldman HB; Moore CK; Rackley RR; Vasavada SP
J Urol; 2017 Jul; 198(1):161-166. PubMed ID: 28192077
[TBL] [Abstract][Full Text] [Related]
4. Six years of experience with sacral nerve stimulation for fecal incontinence.
Michelsen HB; Thompson-Fawcett M; Lundby L; Krogh K; Laurberg S; Buntzen S
Dis Colon Rectum; 2010 Apr; 53(4):414-21. PubMed ID: 20305440
[TBL] [Abstract][Full Text] [Related]
5. Pediatric sacral nerve stimulator explanation due to complications or cure: a survival analysis.
Rensing AJ; Szymanski KM; Dunn S; King S; Cain MP; Whittam BM
J Pediatr Urol; 2019 Feb; 15(1):39.e1-39.e6. PubMed ID: 30473473
[TBL] [Abstract][Full Text] [Related]
6. Sacral nerve modulation for faecal incontinence: influence of age on outcomes and complications. A multicentre study.
Mege D; Meurette G; Brochard C; Damon H; Lambrescak E; Faucheron JL; Wyart V; Lehur PA; Sielezneff I; Siproudhis L; Mion F; Etienney I; Houivet E; Bridoux V; Leroi AM
Colorectal Dis; 2019 Sep; 21(9):1058-1066. PubMed ID: 30985984
[TBL] [Abstract][Full Text] [Related]
7. Sacral nerve stimulation for fecal incontinence: causes of surgical revision from a series of 87 consecutive patients operated on in a single institution.
Faucheron JL; Voirin D; Badic B
Dis Colon Rectum; 2010 Nov; 53(11):1501-7. PubMed ID: 20940598
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and safety of sacral nerve stimulation for fecal incontinence.
Mellgren A; Wexner SD; Coller JA; Devroede G; Lerew DR; Madoff RD; Hull T;
Dis Colon Rectum; 2011 Sep; 54(9):1065-75. PubMed ID: 21825885
[TBL] [Abstract][Full Text] [Related]
10. Sacral neuromodulation for fecal incontinence in Latin America: initial results of a multicenter study.
Oliveira L; Hagerman G; Torres ML; Lumi CM; Siachoque JAC; Reyes JC; Perez-Aguirre J; Sanchez-Robles JC; Guerrero-Guerrero VH; Regadas SM; Filho VG; Rosato G; Vieira E; Marzan L; Lima D; Londoño-Schimmer E; Wexner SD
Tech Coloproctol; 2019 Jun; 23(6):545-550. PubMed ID: 31190233
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with percutaneous nerve evaluation and permanent sacral nerve modulation outcome in patients with fecal incontinence.
Govaert B; Melenhorst J; Nieman FH; Bols EM; van Gemert WG; Baeten CG
Dis Colon Rectum; 2009 Oct; 52(10):1688-94. PubMed ID: 19966599
[TBL] [Abstract][Full Text] [Related]
12. Disparities in the Use of Sacral Neuromodulation among Medicare Beneficiaries.
Laudano MA; Seklehner S; Sandhu J; Reynolds WS; Garrett KA; Milsom JW; Te AE; Kaplan SA; Chughtai B; Lee RK
J Urol; 2015 Aug; 194(2):449-53. PubMed ID: 25846418
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for successful sacral nerve stimulation in the treatment of fecal incontinence: lessons from a comprehensive treatment assessment.
Roy AL; Gourcerol G; Menard JF; Michot F; Leroi AM; Bridoux V
Dis Colon Rectum; 2014 Jun; 57(6):772-80. PubMed ID: 24807603
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Article: Percutaneous Nerve Evaluation Versus Staged Sacral Nerve Stimulation for Fecal Incontinence.
Rice TC; Quezada Y; Rafferty JF; Paquette IM
Dis Colon Rectum; 2016 Oct; 59(10):962-7. PubMed ID: 27602927
[TBL] [Abstract][Full Text] [Related]
15. Trends in Surgeon-Level Utilization of Sacral Nerve Stimulator Implantation for Fecal Incontinence in New York State.
Xu Z; Fleming FJ; Justiniano CF; Becerra AZ; Boodry CI; Aquina CT; Temple LK; Speranza JR
Dis Colon Rectum; 2018 Jan; 61(1):107-114. PubMed ID: 29215481
[TBL] [Abstract][Full Text] [Related]
16. Reoperation after sacral neuromodulation therapy: a single-institution experience.
Shih C; Miller JL; Fialkow M; Vicars BG; Yang CC
Female Pelvic Med Reconstr Surg; 2013; 19(3):175-8. PubMed ID: 23611937
[TBL] [Abstract][Full Text] [Related]
17. Battery explantation after sacral neuromodulation in the Medicare population.
Cameron AP; Anger JT; Madison R; Saigal CS; Clemens JQ;
Neurourol Urodyn; 2013 Mar; 32(3):238-41. PubMed ID: 22847359
[TBL] [Abstract][Full Text] [Related]
18. Outcome of sacral nerve stimulation for fecal incontinence at 5 years.
Maeda Y; Lundby L; Buntzen S; Laurberg S
Ann Surg; 2014 Jun; 259(6):1126-31. PubMed ID: 23817505
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of sacral neuromodulation for lower urinary tract dysfunction: A 23-year experience.
Gandhi S; Gajewski JB; Koziarz A; Almutairi S; Ali A; Cox A
Neurourol Urodyn; 2021 Jan; 40(1):461-469. PubMed ID: 33232534
[TBL] [Abstract][Full Text] [Related]
20. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence.
Hull T; Giese C; Wexner SD; Mellgren A; Devroede G; Madoff RD; Stromberg K; Coller JA;
Dis Colon Rectum; 2013 Feb; 56(2):234-45. PubMed ID: 23303153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
